Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Life

Why Jewish Women Are a Challenging Demographic in Fight Against Breast Cancer

Public health officials trying to fight breast cancer in Australia find the country’s Jewish population especially challenging.

That’s because Australia’s Jewish community of 112,000 is overwhelmingly Ashkenazi, or of European origin, and counts a high number of descendents of Holocaust survivors, said Lesley Andrews, a doctor at Prince of Whales hospital in Randwick, Australia. Andrews presented at “Lessons from the Jewish Genome,” a conference on Jewish genetics in Haifa on July 13.

Ashkenazi Jews are about 10 times more likely than the general population to have BRCA1 and BRCA2 gene mutations, those harmful mutations that can lead to the development of breast cancer.

The decision to get tested for these gene mutations often hinges on family history. If other female relatives were diagnosed with breast cancer, it’s a clear sign that a woman should get tested herself. But many Australian Jews don’t know their family’s long-term cancer history because their family ties were severed in the Holocaust.

Andrews, along with researchers Nicole Cousens and Bettine Meiser, conducted a survey in the Australian Jewish community about the possibility of creating community program that would make it easier for Australian Jews to get tested, regardless of family breast cancer history. The “bottom line” is saving women’s lives, Andrews said.

Of the 370 respondents, “97 percent supported a Jewish community-based BRCA 1/2 testing program, and 66% reported being personally interested in undergoing the test,” according to an abstract provided by the researchers.

Andrews and her co-researchers proposed creating an interactive web site to support Jewish community members with counseling around the topic of genetic testing.

Contact Naomi Zeveloff at Zeveloff@forward.com or on Twitter @naomizeveloff

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

Now more than ever, American Jews need independent news they can trust, with reporting driven by truth, not ideology. We serve you, not any ideological agenda.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and the protests on college campuses.

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

Make a gift of any size and become a Forward member today. You’ll support our mission to tell the American Jewish story fully and fairly. 

— Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at editorial@forward.com, subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.

Exit mobile version